Results 71 to 80 of about 474,370 (295)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Consistency of the proposed additive measures of revealed comparative advantage [PDF]

The recently proposed additive measures of revealed comparative advantage (RCA) have been argued as better alternatives to the Balassa Index. This note builds on those suggestions and provides a framework to assess their applicability by means of their ...
Ufuk gunes Bebek
core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Competitiveness and Diversification in Grape Exports: Keys to Their Sustainability in Global Markets

Agriculture
This study examined the sustainability of global table grape exports from 2020 to 2024, focusing on two key dimensions: market diversification and international competitiveness.
Hugo Daniel García Juárez, Jose Carlos Montes Ninaquispe, Sandra Lizzette León Luyo, Heyner Yuliano Marquez Yauri, Carlos Enrique Mendoza Ocaña, Nelly Victoria De La Cruz Ruiz, Sarita Jessica Apaza Miranda, Christian David Corrales Otazú, Antonio Rafael Rodríguez Abraham, Groover Valenty Villanueva Butrón   +9 more
doaj   +1 more source

Comparative Advantage: Theory, Empirical Measures And Case Studies [PDF]

This paper consists of three main parts i.e. theory, analytical tool and case studies of comparative advantage. Firstly, we review the theory and various empirical measures of comparative advantage. We would argue that for the catching-up economies, like
Tri WIDODO
core  

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

What do alternative measures of comparative advantage reveal about the composition of developing countries'exports? [PDF]

Despite their extensive applications in research and policy studies, no product level comparisons had been made between Bela Balassa's"revealed"comparative advantage (RCA) index and indices associated with the National Bureau of Economic Research (NBER ...
Yeats, Alexander J.
core  

Consistencia de indicadores de especialización en el comercio internacional: Plicación al caso de la mantequilla en Argentina y Uruguay [PDF]

, 2010
This study aims to evaluate, in terms of their cardinal, ordinal, and dichotomy consistency, five alternative comercial specialization indicators: a Balassa symmetric index version; a Chi-Squared Index; and the Relative Trade Advantage Index, all these ...
Depetris Guiguet, Edith, García Arancibia, Rodrigo, Rossini, Gustavo   +2 more
core  

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Revealed Comparative Advantage and the Alternatives as Measures of International Specialisation [PDF]

The paper is an analysis of Balassa’s ‘revealed comparative advantage’ (RCA). The papers shows that when using the RCA, it should always be adjusted in such a way, so that it becomes symmetric.
Keld Laursen
core